Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis.

Pasea L, Chung SC, Pujades-Rodriguez M, Shah AD, Alvarez-Madrazo S, Allan V, Teo JT, Bean D, Sofat R, Dobson R, Banerjee A, Patel RS, Timmis A, Denaxas S, Hemingway H.

BMC Med. 2019 Nov 20;17(1):206. doi: 10.1186/s12916-019-1438-y.


UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER.

Denaxas S, Gonzalez-Izquierdo A, Direk K, Fitzpatrick NK, Fatemifar G, Banerjee A, Dobson RJB, Howe LJ, Kuan V, Lumbers RT, Pasea L, Patel RS, Shah AD, Hingorani AD, Sudlow C, Hemingway H.

J Am Med Inform Assoc. 2019 Dec 1;26(12):1545-1559. doi: 10.1093/jamia/ocz105.


Time spent at blood pressure target and the risk of death and cardiovascular diseases.

Chung SC, Pujades-Rodriguez M, Duyx B, Denaxas SC, Pasea L, Hingorani A, Timmis A, Williams B, Hemingway H.

PLoS One. 2018 Sep 5;13(9):e0202359. doi: 10.1371/journal.pone.0202359. eCollection 2018.


An electronic health records cohort study on heart failure following myocardial infarction in England: incidence and predictors.

Gho JMIH, Schmidt AF, Pasea L, Koudstaal S, Pujades-Rodriguez M, Denaxas S, Shah AD, Patel RS, Gale CP, Hoes AW, Cleland JG, Hemingway H, Asselbergs FW.

BMJ Open. 2018 Mar 3;8(3):e018331. doi: 10.1136/bmjopen-2017-018331. Erratum in: BMJ Open. 2018 Mar 22;8(3):e018331corr1.


Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.

Pasea L, Chung SC, Pujades-Rodriguez M, Moayyeri A, Denaxas S, Fox KAA, Wallentin L, Pocock SJ, Timmis A, Banerjee A, Patel R, Hemingway H.

Eur Heart J. 2017 Apr 7;38(14):1048-1055. doi: 10.1093/eurheartj/ehw683.


Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.

Timmis A, Rapsomaniki E, Chung SC, Pujades-Rodriguez M, Moayyeri A, Stogiannis D, Shah AD, Pasea L, Denaxas S, Emmas C, Hemingway H.

BMJ. 2016 Jun 22;353:i3163. doi: 10.1136/bmj.i3163.


Early graft loss after kidney transplantation: risk factors and consequences.

Hamed MO, Chen Y, Pasea L, Watson CJ, Torpey N, Bradley JA, Pettigrew G, Saeb-Parsy K.

Am J Transplant. 2015 Jun;15(6):1632-43. doi: 10.1111/ajt.13162. Epub 2015 Feb 23.


Study of induction of Tolerance to Oral Peanut: a randomised controlled trial of desensitisation using peanut oral immunotherapy in children (STOP II).

Anagnostou K, Islam S, King Y, Foley L, Pasea L, Palmer C, Bond S, Ewan P, Clark A.

Southampton (UK): NIHR Journals Library; 2014 Dec.


Analysis of ischemia/reperfusion injury in time-zero biopsies predicts liver allograft outcomes.

Ali JM, Davies SE, Brais RJ, Randle LV, Klinck JR, Allison ME, Chen Y, Pasea L, Harper SF, Pettigrew GJ.

Liver Transpl. 2015 Apr;21(4):487-99. doi: 10.1002/lt.24072.


Prevention of retinal detachment in Stickler syndrome: the Cambridge prophylactic cryotherapy protocol.

Fincham GS, Pasea L, Carroll C, McNinch AM, Poulson AV, Richards AJ, Scott JD, Snead MP.

Ophthalmology. 2014 Aug;121(8):1588-97. doi: 10.1016/j.ophtha.2014.02.022. Epub 2014 May 1.


Pre-dialysis systolic blood pressure-variability is independently associated with all-cause mortality in incident haemodialysis patients.

Selvarajah V, Pasea L, Ojha S, Wilkinson IB, Tomlinson LA.

PLoS One. 2014 Jan 28;9(1):e86514. doi: 10.1371/journal.pone.0086514. eCollection 2014.


Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.

Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A.

Lancet. 2014 Apr 12;383(9925):1297-1304. doi: 10.1016/S0140-6736(13)62301-6. Epub 2014 Jan 30.

Supplemental Content

Support Center